Literature DB >> 28315313

Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model.

Miguel Á Manzanares1, Akihiro Usui1, Deanna J Campbell1, Catherine I Dumur1, Gabrielle T Maldonado1, Michel Fausther2, Jonathan A Dranoff2, Alphonse E Sirica3.   

Abstract

To gain insight into the cellular and molecular interactions mediating the desmoplastic reaction and aggressive malignancy of mass-forming intrahepatic cholangiocarcinoma (ICC), we modeled ICC desmoplasia and progression in vitro. A unique three-dimensional (3D) organotypic culture model was established; within a dilute collagen-type I hydrogel, a novel clonal strain of rat cancer-associated myofibroblasts (TDFSM) was co-cultured with a pure rat cholangiocarcinoma cell strain (TDECC) derived from the same ICC type as TDFSM. This 3D organotypic culture model reproduced key features of desmoplastic reaction that closely mimicked those of the in situ tumor, as well as promoted cholangiocarcinoma cell growth and progression. Our results supported a resident liver mesenchymal cell origin of the TDFSM cells, which were not neoplastically transformed. Notably, 3D co-culturing of TDECC cells with TDFSM cells provoked the formation of a dense fibrocollagenous stroma in vitro that was associated with significant increases in both proliferative TDFSM myofibroblastic cells and TDECC cholangiocarcinoma cells accumulating within the gel matrix. This dramatic desmoplastic ICC-like phenotype, which was not observed in the TDECC or TDFSM controls, was highly dependent on transforming growth factor (TGF)-β, but not promoted by TGF-α. However, TGF-α was determined to be a key factor for promoting cholangiocarcinoma cell anaplasia, hyperproliferation, and higher malignant grading in this 3D culture model of desmoplastic ICC.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28315313      PMCID: PMC5417049          DOI: 10.1016/j.ajpath.2017.01.013

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  66 in total

1.  Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells.

Authors:  Uri Ben-David; Yoav Mayshar; Nissim Benvenisty
Journal:  Cell Stem Cell       Date:  2011-08-05       Impact factor: 24.633

2.  Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions.

Authors:  Marco Massani; Tommaso Stecca; Luca Fabris; Ezio Caratozzolo; Cesare Ruffolo; Alberto Furlanetto; Stuart Morton; Massimiliano Cadamuro; Mario Strazzabosco; Nicolò Bassi
Journal:  Oncol Rep       Date:  2013-06-26       Impact factor: 3.906

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1.

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Tse-Ching Chen; Miin-Fu Chen; Ta-Sen Yeh; Yi-Yin Jan; Shiu-Feng Huang; Yuji Nimura; Yasuni Nakanuma
Journal:  Lab Invest       Date:  2005-04       Impact factor: 5.662

5.  Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes.

Authors:  Raghu Kadaba; Hanna Birke; Jun Wang; Steven Hooper; Claudia D Andl; Francesco Di Maggio; Erdinc Soylu; Mohammed Ghallab; Daniel Bor; Fieke Em Froeling; Satyajit Bhattacharya; Anil K Rustgi; Erik Sahai; Claude Chelala; Peter Sasieni; Hemant M Kocher
Journal:  J Pathol       Date:  2013-03-21       Impact factor: 7.996

6.  Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma.

Authors:  Hirohisa Okabe; Toru Beppu; Hiromitsu Hayashi; Kei Horino; Toshiro Masuda; Hiroyuki Komori; Shinji Ishikawa; Masayuki Watanabe; Hiroshi Takamori; Ken-ichi Iyama; Hideo Baba
Journal:  Ann Surg Oncol       Date:  2009-06-23       Impact factor: 5.344

7.  Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms.

Authors:  Brahma N Singh; Junsheng Fu; Rakesh K Srivastava; Sharmila Shankar
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

8.  The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis.

Authors:  Caecilia Hapsari Ceriapuri Sukowati; Beatrice Anfuso; Lory Saveria Crocé; Claudio Tiribelli
Journal:  BMC Cancer       Date:  2015-03-27       Impact factor: 4.430

9.  Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.

Authors:  Kusumawadee Utispan; Peti Thuwajit; Yoshimitsu Abiko; Komgrid Charngkaew; Anucha Paupairoj; Siri Chau-in; Chanitra Thuwajit
Journal:  Mol Cancer       Date:  2010-01-24       Impact factor: 27.401

10.  Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats.

Authors:  Hong Ling; Eric Roux; Donna Hempel; Jingzang Tao; Mandy Smith; Scott Lonning; Anna Zuk; Cynthia Arbeeny; Steve Ledbetter
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

View more
  8 in total

Review 1.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management.

Authors:  Jesus M Banales; Jose J G Marin; Angela Lamarca; Pedro M Rodrigues; Shahid A Khan; Lewis R Roberts; Vincenzo Cardinale; Guido Carpino; Jesper B Andersen; Chiara Braconi; Diego F Calvisi; Maria J Perugorria; Luca Fabris; Luke Boulter; Rocio I R Macias; Eugenio Gaudio; Domenico Alvaro; Sergio A Gradilone; Mario Strazzabosco; Marco Marzioni; Cédric Coulouarn; Laura Fouassier; Chiara Raggi; Pietro Invernizzi; Joachim C Mertens; Anja Moncsek; Sumera Rizvi; Julie Heimbach; Bas Groot Koerkamp; Jordi Bruix; Alejandro Forner; John Bridgewater; Juan W Valle; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-30       Impact factor: 46.802

Review 2.  Proteinaceous Hydrogels for Bioengineering Advanced 3D Tumor Models.

Authors:  Barbara Blanco-Fernandez; Vítor M Gaspar; Elisabeth Engel; João F Mano
Journal:  Adv Sci (Weinh)       Date:  2021-01-04       Impact factor: 16.806

3.  Substance P Reduces Infarct Size and Mortality After Ischemic Stroke, Possibly Through the M2 Polarization of Microglia/Macrophages and Neuroprotection in the Ischemic Rat Brain.

Authors:  Woosung Ahn; Guangfan Chi; Sumin Kim; Youngsook Son; Mingzi Zhang
Journal:  Cell Mol Neurobiol       Date:  2022-09-16       Impact factor: 4.231

Review 4.  Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.

Authors:  Alphonse E Sirica; Mario Strazzabosco; Massimiliano Cadamuro
Journal:  Adv Cancer Res       Date:  2020-12-09       Impact factor: 6.242

5.  Overexpression of periostin and distinct mesothelin forms predict malignant progression in a rat cholangiocarcinoma model.

Authors:  Miguel Á Manzanares; Deanna J W Campbell; Gabrielle T Maldonado; Alphonse E Sirica
Journal:  Hepatol Commun       Date:  2017-12-18

Review 6.  Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.

Authors:  Alphonse E Sirica; Gregory J Gores; John D Groopman; Florin M Selaru; Mario Strazzabosco; Xin Wei Wang; Andrew X Zhu
Journal:  Hepatology       Date:  2019-03-25       Impact factor: 17.298

Review 7.  Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma.

Authors:  Burcin Ekser; Gianfranco Alpini; Keisaku Sato; Wenjun Zhang; Samira Safarikia; Abdulkadir Isidan; Angela M Chen; Ping Li; Heather Francis; Lindsey Kennedy; Leonardo Baiocchi; Domenico Alvaro; Shannon Glaser
Journal:  Hepatology       Date:  2021-06-04       Impact factor: 17.298

Review 8.  Targeting tumor-associated macrophages to synergize tumor immunotherapy.

Authors:  Xiaonan Xiang; Jianguo Wang; Di Lu; Xiao Xu
Journal:  Signal Transduct Target Ther       Date:  2021-02-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.